{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:14:45Z","timestamp":1793394885201,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.dsx.2026.103380","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T06:29:18Z","timestamp":1769927358000},"page":"103380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Performance of fibrosis-4 and NAFLD fibrosis score for screening liver fibrosis in Indian individuals with type 2 diabetes: a prospective cross-sectional study"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4387-0036","authenticated-orcid":false,"given":"Narendra Singh","family":"Choudhary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Shafi","family":"Kuchay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapnil","family":"Dhampalwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunwar Ashish","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gargi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Saraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Duseja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2026.103380_bib1","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jceh.2021.11.010","article-title":"Prevalence of non-alcoholic fatty liver disease in India: a systematic review and meta-analysis","volume":"12","author":"Shalimar","year":"2022","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.dsx.2026.103380_bib2","article-title":"Prediction of nonalcoholic fatty liver in prospective liver donors","author":"Choudhary","year":"2016","journal-title":"Clin Transplant"},{"key":"10.1016\/j.dsx.2026.103380_bib3","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jceh.2021.01.004","article-title":"Non-alcoholic fatty liver in the lean: clinico-biochemical correlates of histopathology in 157 liver biopsies from healthy liver donors","volume":"11","author":"Choudhary","year":"2021","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.dsx.2026.103380_bib4","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/jgh3.12606","article-title":"Prevalence of clinically relevant liver fibrosis due to nonalcoholic fatty liver disease in Indian individuals with type 2 diabetes","volume":"5","author":"Kuchay","year":"2021","journal-title":"JGH Open"},{"key":"10.1016\/j.dsx.2026.103380_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jceh.2022.11.014","article-title":"Indian National Association for Study of the Liver (INASL) guidance paper on nomenclature, diagnosis and treatment of nonalcoholic Fatty Liver disease (NAFLD)","volume":"13","author":"Duseja","year":"2023","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.dsx.2026.103380_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/cld.726","article-title":"Spotlight on impactful research: increased risk of mortality by fibrosis stage in Nonalcoholic Fatty liver disease: systemic review and meta-analysis","volume":"12","author":"von Roenn","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.dsx.2026.103380_bib7","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1007\/s10620-021-07089-w","article-title":"Incidence of complications from percutaneous Biopsy in chronic liver disease: a systematic review and meta-analysis","volume":"67","author":"Thomaides-Brears","year":"2022","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dsx.2026.103380_bib8","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/j.cgh.2023.03.042","article-title":"Noninvasive assessment of liver fibrosis in NAFLD","volume":"21","author":"Sanyal","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dsx.2026.103380_bib9","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/gut.2007.146019","article-title":"Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease","volume":"57","author":"Harrison","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.dsx.2026.103380_bib10","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.dsx.2026.103380_bib11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep.25772","article-title":"Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis","volume":"56","author":"Loomba","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.dsx.2026.103380_bib12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.clnesp.2021.08.028","article-title":"High prevalence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus","volume":"46","author":"Gupta","year":"2021","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.dsx.2026.103380_bib13","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.gastro.2023.04.025","article-title":"NASH clinical research network; loomba R. Fibrosis progression rate in biopsy-proven nonalcoholic Fatty liver disease among people with diabetes versus people without diabetes: a multicenter Study","volume":"165","author":"Huang","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dsx.2026.103380_bib14","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/hep.29302","article-title":"Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis","volume":"66","author":"Xiao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.dsx.2026.103380_bib15","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1007\/s10620-023-08085-y","article-title":"Poor performance of non-invasive tests for advanced fibrosis in nonalcoholic Fatty liver disease: a multicentric Asian Study","volume":"68","author":"Arora","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dsx.2026.103380_bib16","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.dsx.2026.103380_bib17","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.dsx.2026.103380_bib18","doi-asserted-by":"crossref","unstructured":"Steering Committee, Misra A, Kumar A, Kuchay MS, Ghosh A, Gulati S, Choudhary NS, et al, Delphi Committee, Consensus Guidelines for the diagnosis and management of Metabolic dysfunction-associated steatotic liver disease in adult Asian Indians with type 2 diabetes, Diabetes Metabol Syndr: Clin Res Rev, https:\/\/doi.org\/10.1016\/j.dsx.2025.103209.","DOI":"10.1016\/j.dsx.2025.103209"},{"key":"10.1016\/j.dsx.2026.103380_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2025.103468","article-title":"Type 2 diabetes mellitus and risk of advanced fibrosis in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) - the results of multi-centre Indian Consortium on MASLD (ICOM-D) Study","author":"Choudhary","year":"2026","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.dsx.2026.103380_bib20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2013.04.027","article-title":"A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver","volume":"59","author":"Pais","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.dsx.2026.103380_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2004.09.012","article-title":"The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies","volume":"42","author":"Adams","year":"2005","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.dsx.2026.103380_bib22","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.cgh.2021.12.034","article-title":"Low accuracy of FIB-4 and NAFLD fibrosis scores for screening for liver fibrosis in the population","volume":"20","author":"Graupera","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dsx.2026.103380_bib23","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s13300-025-01764-1","article-title":"Prevalence of hepatic steatosis and fibrosis in Asian Indian individuals with type 2 diabetes","volume":"16","author":"Bhuvanesswar","year":"2025","journal-title":"Diabetes Ther"},{"issue":"1","key":"10.1016\/j.dsx.2026.103380_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-10871-9","article-title":"MISHTI study evaluating hepatic fibrosis in type 2 diabetes patients in India","volume":"15","author":"Datta","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.dsx.2026.103380_bib25","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/apt.17688","article-title":"Prospective direct comparison of non-invasive liver tests in outpatients with type 2 diabetes using intention-to-diagnose analysis","volume":"58","author":"Poynard","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dsx.2026.103380_bib26","doi-asserted-by":"crossref","first-page":"E925","DOI":"10.1503\/cmaj.221802","article-title":"The association of sensitivity and specificity with disease prevalence: analysis of 6909 studies of diagnostic test accuracy","volume":"195","author":"Murad","year":"2023","journal-title":"CMAJ (Can Med Assoc J)"},{"key":"10.1016\/j.dsx.2026.103380_bib27","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/(SICI)1097-0258(19970515)16:9<981::AID-SIM510>3.0.CO;2-N","article-title":"Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence","volume":"16","author":"Brenner","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.dsx.2026.103380_bib28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/ijem.IJEM_122_19","article-title":"Vitamin B12 deficiency is endemic in Indian population: a perspective from North India","volume":"23","author":"Singla","year":"2019","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.dsx.2026.103380_bib29","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.4103\/jfmpc.jfmpc_650_21","article-title":"Vitamin B12 deficiency in northern India tertiary care: prevalence, risk factors and clinical characteristics","volume":"11","author":"Singh","year":"2022","journal-title":"J Fam Med Prim Care"},{"issue":"5","key":"10.1016\/j.dsx.2026.103380_bib30","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis","volume":"112","author":"McPherson","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dsx.2026.103380_bib31","article-title":"Diagnostic accuracy of non-invasive tests for MASLD across age, type 2 diabetes, and obesity subgroups: a multinational study","volume":"S1542-3565(26)00044-3","author":"Younossi","year":"2026","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187140212600007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187140212600007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T12:16:06Z","timestamp":1773317766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187140212600007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S187140212600007X"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2026.103380","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of fibrosis-4 and NAFLD fibrosis score for screening liver fibrosis in Indian individuals with type 2 diabetes: a prospective cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2026.103380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103380"}}